COVID-19 Symposium within NANOTEXNOLOGY 2020

COVID-19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. The efforts to control, monitor and cure the pandemic demand a multidisciplinary approach in order to mitigate the many clinical, public health management, social, political and economic challenges. The role of nanotechnology is pivotal in the fight against COVID-19. If this disease persists beyond this year, we must adjust our research to address the significant stress that COVID-19 places on our healthcare systems. The nanotechnology community can contribute significantly in the fight against COVID-19. Nanomaterials, biosensors and nano-drug systems have been used for the development of point-of-care diagnostics, carriers for therapeutics, and vaccine development.

We know that many of you are directly and indirectly engaged in the fight against this disease. To provide a platform for discussion, NANOTEXNOLOGY is going to organize a Symposium related to COVID-19 in order to discuss the latest trends, challenges and possible solutions, during the NANOMEDICINE WORKSHOP. You are cordially invited to attend the Symposium by submitting your abstract and your research.

We recommend a number of research targets and topics to be addressed in the Symposium:

• Cost- effective and rapid point-of-care diagnostics
• 3D-Printing: rapid prototyping of highly efficient PPE and other tools against COVID
• Nano-biosensors and Biomedical Nanotechnology for viruses and bacteria, and quick detection and monitoring the traffic and spreading patterns of viral infections
• Nanomaterials, Nano-formulations, Nanoparticles and Nanofilters against COVID-19
• Mineral nanocrystal based coating completely breaks down any organic contaminants
• Rapid antibody IgM/IgG tests: sensitivity/specificity/time to results/cost
• Vaccine development for the disease prevention front
• Coronavirus Diagnostics and Coronavirus Structure
• Theranostics and Therapeutics. Basic studies of the nano-bio interactions could be adapted to understand how SARS-CoV-2 infects their cells
• Drug formulations to treat patients suffering with COVID-19

Invited Speakers (tentative list)

	Prof. Thomas Webster, Northwestern University, USA Commercializing Improved Prevention, Diagnostic, and Therapeutic Approaches
	Dr. Ilise Feitshans, European Scientific Institute, France & Executive Director The Work Health & Survival Project, EU/USA Snapshot from the trenches of law and pharmacy: Saving the world from Covid-19 by Applying Nanotechnology